Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY)

119 filings reported holding INZY - Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share as of Q1 2025.
Inozyme Pharma, Inc. - Common Stock, par value $0.0001 per share (INZY) has 97 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 46.7M shares of 65M outstanding shares and own 71.92% of the company stock.
Largest 10 shareholders include ADAGE CAPITAL PARTNERS GP, L.L.C. (5.16M shares), Pivotal bioVenture Partners Investment Advisor LLC (4.49M shares), Sofinnova Investments, Inc. (4.28M shares), Affinity Asset Advisors, LLC (3.87M shares), BlackRock, Inc. (3.75M shares), Rock Springs Capital Management LP (3.45M shares), VANGUARD GROUP INC (2.76M shares), NEA Management Company, LLC (2.44M shares), SAMSARA BIOCAPITAL, LLC (1.56M shares), and MILLENNIUM MANAGEMENT LLC (1.24M shares).
This table shows the top 97 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.